Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Reply to T. Sio et al.

Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Bradley JD.

J Clin Oncol. 2019 Aug 29:JCO1901663. doi: 10.1200/JCO.19.01663. [Epub ahead of print] No abstract available.

PMID:
31465262
2.

A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.

Munoz-Schuffenegger P, Kandel S, Alibhai Z, Hope A, Bezjak A, Sun A, Simeonov A, Cho BCJ, Giuliani M.

Clin Oncol (R Coll Radiol). 2019 Oct;31(10):720-727. doi: 10.1016/j.clon.2019.05.014. Epub 2019 Jun 5.

PMID:
31176537
3.

National Trends and Dynamic Responses in the Canadian Radiation Oncology Workforce From 1990 to 2018.

Loewen SK, Doll CM, Halperin R, Parliament M, Pearcey RG, Milosevic MF, Bezjak A, Vigneault E, Brundage M.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):31-41. doi: 10.1016/j.ijrobp.2019.04.019. Epub 2019 Apr 27.

PMID:
31039422
4.

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, Daly ME, Grills IS, Sperduto P, Normolle DP, Bradley JD, Choy H.

J Clin Oncol. 2019 May 20;37(15):1316-1325. doi: 10.1200/JCO.18.00622. Epub 2019 Apr 3.

PMID:
30943123
5.

Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer.

Bang A, Bezjak A.

Transl Lung Cancer Res. 2019 Feb;8(1):58-69. doi: 10.21037/tlcr.2018.10.07. Review.

6.

Exploring the geriatric needs of oncology inpatients at an academic cancer centre.

Rosario CO, Puts M, Jang R, Bezjak A, Yokom D, Alibhai SMH.

J Geriatr Oncol. 2019 Sep;10(5):824-828. doi: 10.1016/j.jgo.2018.12.001. Epub 2018 Dec 23.

PMID:
30587462
7.

Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.

Levy A, Le PĂ©choux C, Mistry H, Martel-Lafay I, Bezjak A, Lerouge D, Padovani L, Taylor P, Faivre-Finn C.

J Thorac Oncol. 2019 Feb;14(2):294-297. doi: 10.1016/j.jtho.2018.09.019. Epub 2018 Oct 4.

PMID:
30292850
8.

Favourable health-related quality of life reported in survivors of thymic malignancies.

Soldera SV, Shakik S, Naik H, Moskovitz M, Chen J, Mittmann N, Xu W, Hope A, Bezjak A, Parajian A, Keshavjee S, Liu G.

Eur J Cardiothorac Surg. 2019 Feb 1;55(2):292-299. doi: 10.1093/ejcts/ezy259.

PMID:
30084958
9.

Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single-Institution Experience.

Raman S, Yau V, Pineda S, Le LW, Lau A, Bezjak A, Cho BCJ, Sun A, Hope AJ, Giuliani M.

Clin Lung Cancer. 2018 Sep;19(5):e803-e810. doi: 10.1016/j.cllc.2018.06.001. Epub 2018 Jun 18.

PMID:
30007498
10.

Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).

Raman S, Bissonnette JP, Warner A, Le L, Bratman S, Leighl N, Bezjak A, Palma D, Schellenberg D, Sun A.

Clin Lung Cancer. 2018 Sep;19(5):e699-e703. doi: 10.1016/j.cllc.2018.05.002. Epub 2018 May 16.

PMID:
29903551
11.

Low Incidence of Esophageal Toxicity After Lung Stereotactic Body Radiation Therapy: Are Current Esophageal Dose Constraints Too Conservative?

Yau V, Lindsay P, Le L, Lau A, Wong O, Glick D, Bezjak A, Cho BCJ, Hope A, Sun A, Giuliani M.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):574-580. doi: 10.1016/j.ijrobp.2018.02.025. Epub 2018 Mar 2.

PMID:
29680259
12.

A two-dimensional model of disrupted body integrity: initial evaluation in head and neck cancer.

Mah K, Lebel S, Irish J, Bezjak A, Payne AYM, Devins GM.

Support Care Cancer. 2018 Oct;26(10):3365-3377. doi: 10.1007/s00520-018-4187-0. Epub 2018 Apr 13.

PMID:
29651597
13.

Strategic planning in an academic radiation medicine program.

Hamilton JL, Foxcroft S, Moyo E, Cooke-Lauder J, Spence T, Zahedi P, Bezjak A, Jaffray D, Lam C, LĂ©tourneau D, Milosevic M, Tsang R, Wong R, Liu FF.

Curr Oncol. 2017 Dec;24(6):e518-e523. doi: 10.3747/co.24.3725. Epub 2017 Dec 20.

14.

Serial 4DCT/4DPET imaging to predict and monitor response for locally-advanced non-small cell lung cancer chemo-radiotherapy.

Bissonnette JP, Yap ML, Clarke K, Shessel A, Higgins J, Vines D, Atenafu EG, Becker N, Leavens C, Bezjak A, Jaffray DA, Sun A.

Radiother Oncol. 2018 Feb;126(2):347-354. doi: 10.1016/j.radonc.2017.11.023. Epub 2017 Dec 12.

PMID:
29246584
15.

Genetic biomarkers associated with pain flare and dexamethasone response following palliative radiotherapy in patients with painful bone metastases.

Furfari A, Wan BA, Ding K, Wong A, Zhu L, Bezjak A, Wong R, Wilson CF, DeAngelis C, Azad A, Chow E, Charames GS.

Ann Palliat Med. 2017 Dec;6(Suppl 2):S240-S247. doi: 10.21037/apm.2017.09.04. Epub 2017 Sep 20.

16.

Genetic biomarkers associated with changes in quality of life and pain following palliative radiotherapy in patients with bone metastases.

Furfari A, Wan BA, Ding K, Wong A, Zhu L, Bezjak A, Wong R, Wilson CF, DeAngelis C, Azad A, Chow E, Charames GS.

Ann Palliat Med. 2017 Dec;6(Suppl 2):S248-S256. doi: 10.21037/apm.2017.09.01. Epub 2017 Sep 28.

17.

Genetic biomarkers associated with response to palliative radiotherapy in patients with painful bone metastases.

Furfari A, Wan BA, Ding K, Wong A, Zhu L, Bezjak A, Wong R, Wilson CF, DeAngelis C, Azad A, Chow E, Charames GS.

Ann Palliat Med. 2017 Dec;6(Suppl 2):S233-S239. doi: 10.21037/apm.2017.09.03. Epub 2017 Oct 10.

18.

Leveraging Mobile Technology to Improve Efficiency of the Consent-to-Treatment Process.

Chhin V, Roussos J, Michaelson T, Bana M, Bezjak A, Foxcroft S, Hamilton JL, Liu FF.

JCO Clin Cancer Inform. 2017 Nov;1:1-8. doi: 10.1200/CCI.17.00041.

19.

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).

Glick D, Lyen S, Kandel S, Shapera S, Le LW, Lindsay P, Wong O, Bezjak A, Brade A, Cho BCJ, Hope A, Sun A, Giuliani M.

Clin Lung Cancer. 2018 Mar;19(2):e219-e226. doi: 10.1016/j.cllc.2017.06.021. Epub 2017 Jul 10.

PMID:
29066051
20.

Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy.

Wong OY, Yau V, Kang J, Glick D, Lindsay P, Le LW, Sun A, Bezjak A, Cho BCJ, Hope A, Giuliani M.

Clin Lung Cancer. 2018 Mar;19(2):e241-e246. doi: 10.1016/j.cllc.2017.08.002. Epub 2017 Aug 31.

PMID:
28941961
21.

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A, Bezjak A, Cardenal F, Fournel P, Harden S, Le Pechoux C, McMenemin R, Mohammed N, O'Brien M, Pantarotto J, Surmont V, Van Meerbeeck JP, Woll PJ, Lorigan P, Blackhall F; CONVERT Study Team.

Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20.

22.

Rebuttal from Dr. Bezjak and Dr. Giuliani.

Giuliani M, Bezjak A.

Transl Lung Cancer Res. 2016 Dec;5(6):658-659. doi: 10.21037/tlcr.2016.12.08. No abstract available.

23.

Trimodality Approach to Stage IIIA-N2 NSCLC: As Good as It Gets?

Bezjak A, de Perrot M.

J Thorac Oncol. 2016 Nov;11(11):1817-1818. doi: 10.1016/j.jtho.2016.08.128. No abstract available.

24.

Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer.

Yap ML, Sun A, Higgins J, Clarke K, Marshall A, Becker N, Le LW, Vines DC, Bezjak A, Bissonnette JP.

Clin Oncol (R Coll Radiol). 2016 Dec;28(12):e199-e205. doi: 10.1016/j.clon.2016.08.011. Epub 2016 Sep 13.

PMID:
27637725
25.

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy.

Giuliani M, Sampson LR, Wong O, Gay J, Le LW, Cho BC, Brade A, Sun A, Bezjak A, Hope AJ.

Curr Oncol. 2016 Aug;23(4):e362-8. doi: 10.3747/co.23.3051. Epub 2016 Aug 12.

26.

High Dose Rate Brachytherapy as a Treatment Option in Endobronchial Tumors.

Hosni A, Bezjak A, Rink A, Czarnecka K, McPartlin A, Patterson S, Saibishkumar E.

Lung Cancer Int. 2016;2016:3086148. doi: 10.1155/2016/3086148. Epub 2016 Jul 14.

27.

The Brain Metastases Symptom Checklist as a novel tool for symptom measurement in patients with brain metastases undergoing whole-brain radiotherapy.

Rodin D, Banihashemi B, Wang L, Lau A, Harris S, Levin W, Dinniwell R, Millar BA, Chung C, Laperriere N, Bezjak A, Wong RK.

Curr Oncol. 2016 Jun;23(3):e239-47. doi: 10.3747/co.23.2936. Epub 2016 Jun 9.

28.

Clinical and research priorities for combined modality therapy in stage III NSCLC.

Lin A, Bezjak A.

Lung Cancer Manag. 2016 Apr;5(1):43-50. doi: 10.2217/lmt-2015-0010. Epub 2016 Mar 22. Review.

29.

In the Loop: The Organization of Team-Based Communication in a Patient-Centered Clinical Collaboration System.

Kurahashi AM, Weinstein PB, Jamieson T, Stinson JN, Cafazzo JA, Lokuge B, Morita PP, Cohen E, Rapoport A, Bezjak A, Husain A.

JMIR Hum Factors. 2016 Mar 24;3(1):e12. doi: 10.2196/humanfactors.4996.

30.

Role of palliative radiotherapy in the management of mural cardiac metastases: who, when and how to treat? A case series of 10 patients.

Fotouhi Ghiam A, Dawson LA, Abuzeid W, Rauth S, Jang RW, Horlick E, Bezjak A.

Cancer Med. 2016 Jun;5(6):989-96. doi: 10.1002/cam4.619. Epub 2016 Feb 16.

31.

Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer.

Brade A, MacRae R, Laurie SA, Bezjak A, Burkes R, Chu Q, Goffin JR, Cho J, Hope A, Sun A, Leighl N, Capobianco S, Feld R, Mahalingam E, Hossain A, Iscoe N, Shepherd FA.

Clin Lung Cancer. 2016 Mar;17(2):133-41. doi: 10.1016/j.cllc.2015.12.008. Epub 2015 Dec 21.

PMID:
26872764
32.
33.

Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer.

Mehmood Q, Sun A, Becker N, Higgins J, Marshall A, Le LW, Vines DC, McCloskey P, Ford V, Clarke K, Yap M, Bezjak A, Bissonnette JP.

J Thorac Oncol. 2016 Feb;11(2):213-21. doi: 10.1016/j.jtho.2015.10.006. Epub 2015 Dec 22.

34.

Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy.

Tagawa T, Anraku M, Morodomi Y, Takenaka T, Okamoto T, Takenoyama M, Ichinose Y, Maehara Y, Cho BC, Feld R, Tsao MS, Leighl N, Bezjak A, Keshavjee S, de Perrot M.

J Thorac Dis. 2015 Nov;7(11):1898-906. doi: 10.3978/j.issn.2072-1439.2015.11.15. Erratum in: J Thorac Dis. 2016 Jan;8(1):E161.

35.

Reply to B. Jeremic et al.

Bezjak A, Temin S, Azzoli CG.

J Clin Oncol. 2016 Jan 10;34(2):197-8. doi: 10.1200/JCO.2015.64.1407. Epub 2015 Nov 16. No abstract available.

PMID:
26573071
36.

Sex: Taboos, Assumptions, and Evidence.

Bezjak A, Ferguson SE.

J Clin Oncol. 2015 Oct 20;33(30):3370-1. doi: 10.1200/JCO.2015.62.9899. Epub 2015 Sep 8. No abstract available.

PMID:
26351342
37.

Classification and Reporting of Late Radiographic Changes After Lung Stereotactic Body Radiotherapy: Proposing a New System.

Raziee H, Hope A, Faruqi S, Yap ML, Roberts H, Kandel S, Le LW, Brade A, Cho J, Sun A, Bezjak A, Giuliani ME.

Clin Lung Cancer. 2015 Nov;16(6):e245-51. doi: 10.1016/j.cllc.2015.05.008. Epub 2015 Jun 2.

PMID:
26077096
38.

Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.

Brundage M, Sydes MR, Parulekar WR, Warde P, Cowan R, Bezjak A, Kirkbride P, Parliament M, Moynihan C, Bahary JP, Parmar MK, Sanders K, Chen BE, Mason MD.

J Clin Oncol. 2015 Jul 1;33(19):2151-7. doi: 10.1200/JCO.2014.57.8724. Epub 2015 May 26.

39.

Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care.

Mitera G, Earle C, Latosinsky S, Booth C, Bezjak A, Desbiens C, Delouya G, Laing K, Camuso N, Porter G.

J Oncol Pract. 2015 May;11(3):e296-303. doi: 10.1200/JOP.2015.004325.

PMID:
25980018
40.

Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.

Bezjak A, Temin S, Franklin G, Giaccone G, Govindan R, Johnson ML, Rimner A, Schneider BJ, Strawn J, Azzoli CG.

J Clin Oncol. 2015 Jun 20;33(18):2100-5. doi: 10.1200/JCO.2014.59.2360. Epub 2015 May 5.

PMID:
25944914
41.

Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U).

Chow E, DeAngelis C, Chen BE, Azad A, Meyer RM, Wilson C, Kerba M, Bezjak A, Wilson P, Nabid A, Greenland J, Rees G, Vieth R, Wong RK, Hoskin P.

Radiother Oncol. 2015 Apr;115(1):141-8. doi: 10.1016/j.radonc.2015.02.025. Epub 2015 Mar 14.

PMID:
25782738
42.

Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.

Giuliani ME, Lindsay PE, Kwan JY, Sun A, Bezjak A, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ.

Clin Lung Cancer. 2015 May;16(3):216-20. doi: 10.1016/j.cllc.2014.11.008. Epub 2014 Dec 2.

PMID:
25532963
43.

Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.

Chang JY, Bezjak A, Mornex F; IASLC Advanced Radiation Technology Committee.

J Thorac Oncol. 2015 Apr;10(4):577-85. doi: 10.1097/JTO.0000000000000453. Review.

44.

Long-term outcome after resection of non-small cell lung cancer invading the thoracic inlet.

Collaud S, Machuca T, Mercier O, Waddell TK, Yasufuku K, Pierre AF, Darling GE, Cypel M, Rampersaud YR, Lewis SJ, Shepherd FA, Leighl NB, Cho JB, Bezjak A, Keshavjee S, de Perrot M.

Ann Thorac Surg. 2014 Sep;98(3):962-7. doi: 10.1016/j.athoracsur.2014.05.015. Epub 2014 Jul 25.

PMID:
25069687
45.

Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapy.

Faruqi S, Giuliani ME, Raziee H, Yap ML, Roberts H, Le LW, Brade A, Cho J, Sun A, Bezjak A, Hope AJ.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1076-1083. doi: 10.1016/j.ijrobp.2014.04.042. Epub 2014 Jul 8.

PMID:
25035211
46.

Incidental prophylactic nodal irradiation and patterns of nodal relapse in inoperable early stage NSCLC patients treated with SBRT: a case-matched analysis.

Lao L, Hope AJ, Maganti M, Brade A, Bezjak A, Saibishkumar EP, Giuliani M, Sun A, Cho BC.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):209-15. doi: 10.1016/j.ijrobp.2014.05.006. Epub 2014 Jul 3.

PMID:
24997639
47.

Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy.

Atallah S, Cho BC, Allibhai Z, Taremi M, Giuliani M, Le LW, Brade A, Sun A, Bezjak A, Hope AJ.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):532-8. doi: 10.1016/j.ijrobp.2014.03.003.

PMID:
24929163
48.

Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma.

Safieddine N, Liu G, Cuningham K, Ming T, Hwang D, Brade A, Bezjak A, Fischer S, Xu W, Azad S, Cypel M, Darling G, Yasufuku K, Pierre A, de Perrot M, Waddell T, Keshavjee S.

J Thorac Oncol. 2014 Jul;9(7):1018-22. doi: 10.1097/JTO.0000000000000215.

49.

Stereotactic body radiotherapy in patients with previous pneumonectomy: safety and efficacy.

Thompson R, Giuliani M, Yap ML, Atallah S, Le LW, Sun A, Brade A, Cho BC, Bezjak A, Hope A.

J Thorac Oncol. 2014 Jun;9(6):843-7. doi: 10.1097/JTO.0000000000000159.

50.

No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236.

Stanic S, Paulus R, Timmerman RD, Michalski JM, Barriger RB, Bezjak A, Videtic GM, Bradley J.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1092-9. doi: 10.1016/j.ijrobp.2013.12.050.

Supplemental Content

Loading ...
Support Center